Search Results - "Crinière, E."

Refine Results
  1. 1

    Temozolomide As Initial Treatment for Adults With Low-Grade Oligodendrogliomas or Oligoastrocytomas and Correlation With Chromosome 1p Deletions by HOANG-XUAN, K, CAPELLE, L, CARPENTIER, A. F, LAIGLE, F, SIMON, J. M, CORNU, P, BROËT, P, SANSON, M, DELATTRE, J. Y, KUJAS, M, TAILLIBERT, S, DUFFAU, H, LEJEUNE, J, POLIVKA, M, CRINIERE, E, MARIE, Y, MOKHTARI, K

    Published in Journal of clinical oncology (01-08-2004)
    “…To determine the response rate of low-grade oligodendroglial tumors (LGOT) to temozolomide (TMZ) as initial treatment and to evaluate the predictive value of…”
    Get full text
    Journal Article
  2. 2

    Correlations between molecular profile and radiologic pattern in oligodendroglial tumors by LAIGLE-DONADEY, F, MARTIN-DUVERNEUIL, N, CARPENTIER, A, SANSON, M, HOANG-XUAN, K, THILLET, J, DELATTRE, J. Y, LEJEUNE, J, CRINIERE, E, CAPELLE, L, DUFFAU, H, CORNU, P, BROËT, P, KUJAS, M, MOKHTARI, K

    Published in Neurology (28-12-2004)
    “…To investigate possible correlations between tumor location and genetic alterations in a series of oligodendrogliomas. A series of 158 consecutive…”
    Get full text
    Journal Article
  3. 3

    All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2 by LABUSSIERE, M, IDBAIH, A, DUCRAY, F, EL HALLANI, S, MOKHTARI, K, HOANG-XUAN, K, DELATTRE, J.-Y, SANSON, M, WANG, X.-W, MARIE, Y, BOISSELIER, B, FALET, C, PARIS, S, LAFFAIRE, J, CARPENTIER, C, CRINIERE, E

    Published in Neurology (08-06-2010)
    “…Recently, the gene encoding the human cytosolic NADPH-dependent isocitrate dehydrogenase (IDH1) was reported frequently mutated in gliomas. Rare mutations were…”
    Get full text
    Journal Article
  4. 4

    Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification by Mokhtari, K., Paris, S., Aguirre-Cruz, L., Privat, N., Crinière, E., Marie, Y., Hauw, J.-J., Kujas, M., Rowitch, D., Hoang-Xuan, K., Delattre, J.-Y., Sanson, M.

    Published in Neuropathology and applied neurobiology (01-02-2005)
    “…The expression of Olig2, a basic helix–loop–helix (bHLH) transcription factor involved in oligodendroglial specification, was investigated by…”
    Get full text
    Journal Article
  5. 5

    Multidrug resistance-associated protein MRP1 expression in human gliomas: chemosensitization to vincristine and etoposide by indomethacin in human glioma cell lines overexpressing MRP1 by BENYAHIA, B, HUGUET, S, DECLEVES, X, MOKHTARI, K, CRINIERE, E, BERNAUDIN, J. F, SCHERRMANN, J. M, DELATTRE, J. Y

    Published in Journal of neuro-oncology (2004)
    “…The 190 kDa multidrug resistance protein MRP1 is likely to be involved in the multidrug resistance phenotype of human gliomas. MRP1 expression was evaluated in…”
    Get full text
    Journal Article
  6. 6

    α-Internexin expression identifies 1p19q codeleted gliomas by DUCRAY, F, CRINIERE, E, HOANG-XUAN, K, DELATTRE, J.-Y, SANSON, M, IDBAIH, A, MOKHTARI, K, MARIE, Y, PARIS, S, NAVARRO, S, LAIGLE-DONADEY, F, DEHAIS, C, THILLET, J

    Published in Neurology (13-01-2009)
    “…alpha-Internexin (INA) is a proneural gene encoding a neurofilament interacting protein that is upregulated in some gliomas, particularly oligodendrogliomas…”
    Get full text
    Journal Article
  7. 7

    Telomerase reactivation in malignant gliomas and loss of heterozygosity on 10p15.1 by Leuraud, P, Aguirre-Cruz, L, Hoang-Xuan, K, Crinière, E, Tanguy, M-L, Golmard, J-L, Kujas, M, Delattre, J-Y, Sanson, M

    Published in Neurology (10-06-2003)
    “…An inhibitor of telomerase activity maps to chromosome 10p15.1. A series of 51 high-grade gliomas was analyzed for loss of heterozygosity (LOH) on chromosome…”
    Get full text
    Journal Article
  8. 8

    Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice by LEURAUD, P, TAILLANDIER, L, POUPON, M.-F, SANSON, M, AGUIRRE-CRUZ, L, MEDIONI, J, CRINIERE, E, MARIE, Y, DUTRILLAUX, A. M, KUJAS, M, DUPREZ, A, DELATTRE, J.-Y

    Published in British journal of cancer (15-12-2003)
    “…In order to develop preclinical models of malignant astrocytomas and oligodendrogliomas, a series of 54 resected gliomas (37 from oligodendroglial lineage and…”
    Get full text
    Journal Article
  9. 9

    Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma by Idbaih, A., Aimard, J., Boisselier, B., Marie, Y., Paris, S., Crinière, E., Carvalho Silva, R., Laigle-Donadey, F., Rousseau, A., Mokhtari, K., Thillet, J., Sanson, M., Hoang-Xuan, K., Delattre, J.-Y.

    Published in Neuropathology and applied neurobiology (01-04-2009)
    “…Aims: Novel missense mutations of the epidermal growth factor receptor (EGFR) extracellular domain have been recently described in a large series of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis by Laffaire, Julien, Everhard, Sibille, Idbaih, Ahmed, Crinière, Emmanuelle, Marie, Yannick, de Reyniès, Aurelien, Schiappa, Renaud, Mokhtari, Karima, Hoang-Xuan, Khê, Sanson, Marc, Delattre, Jean-Yves, Thillet, Joëlle, Ducray, François

    Published in Neuro-oncology (Charlottesville, Va.) (01-01-2011)
    “…Extensive genomic and gene expression studies have been performed in gliomas, but the epigenetic alterations that characterize different subtypes of gliomas…”
    Get full text
    Journal Article
  12. 12

    Prognostic impact of molecular markers in a series of 220 primary glioblastomas by Houillier, Caroline, Lejeune, Julie, Benouaich‐Amiel, Alexandra, Laigle‐Donadey, Florence, Criniere, Emmanuelle, Mokhtari, Karima, Thillet, Joelle, Delattre, Jean‐Yves, Hoang‐Xuan, Khe, Sanson, Marc

    Published in Cancer (15-05-2006)
    “…BACKGROUND In contrast to oligodendrogliomas, molecular predictors of prognosis have not been consistently found in glioblastomas. However, genetic studies…”
    Get full text
    Journal Article
  13. 13

    Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas by HESSON, Luke, BIECHE, Ivan, KREX, Dietmar, CRINIERE, Emmanuelle, HOANG-XUAN, Khê, MAHER, Eamonn R, LATIF, Farida

    Published in Oncogene (25-03-2004)
    “…RASSF1A is a major tumor suppressor gene located at 3p21.3. We investigated the role of aberrant promoter region hypermethylation of RASSF1A in a large series…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomas by Houillier, Caroline, Mokhtari, Karima, Carpentier, Catherine, Crinière, Emmanuelle, Marie, Yannick, Rousseau, Audrey, Kaloshi, Gentian, Dehais, Caroline, Laffaire, Julien, Laigle-Donadey, Florence, Hoang-Xuan, Khê, Sanson, Marc, Delattre, Jean-Yves

    Published in Neuro-oncology (Charlottesville, Va.) (01-01-2010)
    “…The loss of chromosomes 1p-19q is the only prognostic molecular alteration identified in low-grade gliomas (LGGs) to date. Search for loss of heterozygosity…”
    Get full text
    Journal Article
  16. 16

    Lymphomes intracrâniens du sujet immunocompétent by Louis, E., Camilleri-Broët, S., Crinière, E., Hoang-Xuan, K.

    Published in EMC. Neurologie (01-05-2005)
    “…Les lymphomes intracrâniens sont représentés dans leur grande majorité par les lymphomes cérébraux primitifs (LCP) dont l’incidence a considérablement augmenté…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Loss of 22q chromosome is related to glioma progression and loss of 10q by LAIGLE-DONADEY, Florence, CRINIERE, Emmanuelle, BENOUAICH, Alexandra, LESUEUR, Emmanuelle, MOKHTARI, Karima, KHE, Hoang-Xuan, SANSON, Marc

    Published in Journal of neuro-oncology (01-02-2006)
    “…Loss of heterozygosity (LOH) of chromosome 22q has been investigated in 160 gliomas. LOH at one or more microsatellite increased with increasing grade of the…”
    Get full text
    Journal Article